Must Play Games brings you “Intruders” - an action-packed 3D mobile game that requires the best game strategies. It’s an action-strategy game with many exciting features. So race against time to protect your base and keep enemies at bay. Rogue forces are on the offensive, quick thinking and strategic planning can save the day!
It’s up to you to conquer the squads of invading enemy robots – using your dual-barrel shooter, Jetpack and Missile Launch… Your only companion, a drone that is at your command to take down enemies where turrets can’t reach… and the upgrades you can unlock…
To view the multimedia release go to:
https://www.multivu.com/players/uk/8059051-tower-defense-game-intruders-strategy/
See America, Allergan’s initiative to fight against preventable blindness in the United States, today unveiled a powerful video featuring award-winning actor and hip-hop artist Common, that urges Americans to “stand in the way of darkness”.
The video harnesses Common’s striking spoken word ability, calling on Americans to fight against vision loss and prioritize their vision. Common highlights the 61 million Americans at-risk of severe vision loss, and challenges us all to imagine a life without sight.
“I'm proud to join Allergan in the fight against preventable blindness,” said Common. “Sight is something that far too many of us take for granted. I hope our message resonates with people across the country, no matter what age or background.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8057551-common-joins-allergan-see-america-against-preventable-blindness/
Tostitos tortilla chips and dips bring people together and are an essential part of most big football watch parties. These gatherings usually feature a spread of food and beverages and, many times, alcohol, leading to an increase in alcohol-related traffic crashes.
Recognizing this, Tostitos created the “Party Safe” bag – a bag of Tostitos chips featuring an alcohol sensor that acts as a reminder for people to not drink and drive after the party so everyone gets home safely. For those not lucky enough to get their hands on one of the limited-edition bags, Tostitos also partnered with Mothers Against Drunk Driving (MADD) to offer party-goers $10 off an Uber ride on Sunday, February 5 by using the barcode on the back of nearly every bag of Tostitos chips. This offer applies to both new and existing customers of Uber, but will be limited to the first 25,000 users who enter the code.
To view the multimedia release go to:
http://www.multivu.com/players/English/8020151-tostitos-super-bowl-madd-party-safe-bag/
Do you know the condition of your vehicle’s battery? For a majority of drivers, the battery is unnoticeable unless the engine refuses to start, which happens more frequently in the cold and rainy winter seasons. “Extreme temperatures, irregular use, short trips and the age of a vehicle influence the starting power of a battery,” says Dr. Christian Rosenkranz, Vice President Engineering at battery manufacturer Johnson Controls. He explains the four main causes of battery failure and how drivers can safeguard against it.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7977951-johnson-controls-batteries-safeguard/
ImageWare Systems, Inc. (ImageWare) (OTCQB: IWSY), a leader in mobile and cloud-based, multi-modal biometric identity management solutions, today introduced GoVerifyID® Enterprise Suite, an innovative, multi-modal, multi-factor biometric authentication solution for the enterprise market. An algorithm-agnostic solution, GoVerifyID Enterprise Suite is the first ever end-to-end biometric platform that seamlessly integrates with an enterprise’s existing Microsoft infrastructure, offering businesses a turnkey biometric solution for quick deployment in an afternoon or less.
“Last year nearly 80 percent of businesses reported a data breach. As the digital workforce expands, with data extended to external stakeholders and across numerous types of devices and systems, the need for high-assurance, enterprise-wide protection has intensified,” said Jim Miller, chairman & CEO of ImageWare. “The traditional security perimeters have changed and executives are being held accountable for safeguarding data against potentially devastating breaches that can tarnish a brand’s reputation. Armed with GoVerifyID Enterprise Suite, corporations have access to a scalable and affordable solution that works with their existing Microsoft infrastructure and gives them the ultimate peace of mind.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7978451-imageware-goverifyid-enterprise-suite/
Ethicon* joins world-renowned experts in bariatric surgery to share the latest breakthroughs in science and innovation that are advancing surgery in the fight against obesity and metabolic diseases during ObesityWeek 2016, the combined annual meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS). Ethicon will highlight the growing body of research and evidence on the benefits of bariatric surgery, a new sleeve gastrectomy training module on the Touch Surgery app, and its comprehensive portfolio of bariatric surgery products aimed to improve patient outcomes.
“Ethicon’s mission is to lead the way in resolving the burden of obesity for both patients and healthcare systems by expanding access to care and demonstrating the critical value of treatment through research and evidence, while also enabling new technologies,” said Dr. Elliott Fegelman, Therapeutic Area Expert, Metabolics, Johnson & Johnson Innovation.
To view the multimedia release go to:
http://www.multivu.com/players/English/7965651-ethicon-bariatric-surgery-access-obesity-week-2016/
Going on the offensive against one of the most daunting challenges in cancer, The Leukemia & Lymphoma Society (LLS) today announced the launch of a groundbreaking, collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease which has seen few improvements in treatments in more than 40 years.
Beat AML was announced yesterday by Vice President Biden, along with many new, Moonshot inspired initiatives across industry, non-profit and government.
AML is the most lethal of the blood cancers, which together are the third leading cause of cancer deaths in the U.S.; AML is responsible for more than 10,000 deaths each year. Despite advances in treating other blood cancers, the standard of treatment for AML – a combination of toxic chemotherapies – has remained the same for more than 40 years. Overall prognosis remains poor, with a five-year survival rate below 20 percent for patients over age 60.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554854-lls-beat-aml-acute-myeloid-leukemia/
The holiday season brings opportunity for retailers – and for hackers looking to invade retail networks, disrupt systems and steal valuable information. To help defend against these threats, Level 3 Communications (NYSE: LVLT) is releasing comprehensive omnichannel security best practices for retailers heading into the 2016 shopping season.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911453-level-3-holiday-ebook-retail-security/
The Ad Council’s I Am A Witness campaign is bringing together the top digital companies in the teen space for the second iteration of the award-winning and unprecedented effort aimed at transforming the “silent majority” of kids who witness bullying each day from passive bystanders into a united, empowered and active collective against bullying. The campaign is the first to create an anti-bullying emoji adopted by Unicode and natively available on nearly all smartphones across the world. There will be activations throughout the month of October to coincide with Bullying Prevention Month.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933951-ad-council-i-am-a-witness-anti-bullying/
Federally funded research continues to spur progress against cancer; however, accelerating the pace of progress will require robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Food and Drug Administration (FDA). Additionally, strong financial support for the National Cancer Moonshot Initiative is required, according to the sixth annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
One of the most exciting new approaches to cancer treatment is cancer immunotherapy. As detailed in the report, the utility of immunotherapy is expanding rapidly. For example, on Aug. 1, 2015, one class of immunotherapeutics, checkpoint inhibitors, was initially approved for just two types of cancer—melanoma and lung cancer. As of Sept. 1, 2016, checkpoint inhibitors have been approved for treating six types of cancer—bladder cancer, head and neck cancer, Hodgkin lymphoma, kidney cancer, lung cancer, and melanoma.
To view the multimedia release go to:
http://www.multivu.com/players/English/7911951-aacr-2016-cancer-progress-report/
Orbis, the international nonprofit that unites the world in the fight against blindness, is proud to land its new, state-of-the-art Flying Eye Hospital in Shenyang, China this week to commence its first training program, running from September 5 - 23. Six years in the making, the third-generation Flying Eye Hospital is the world’s only mobile ophthalmic teaching hospital on board an MD-10 aircraft, donated by FedEx. Hundreds of experts have come together to combine the latest in avionics, hospital engineering, technology and clinical expertise to make the new Flying Eye Hospital a reality. It features modular design, 3D technology and live broadcast capabilities, which enables Orbis and their expert Volunteer Faculty to train more doctors, nurses and healthcare professionals—ultimately treating more people and restoring their sight.
“Today, I am incredibly proud that our Flying Eye Hospital can get to work on its first program,” Bob Ranck, Orbis CEO and President, said. “It is a testament to the hundreds of volunteers, global corporate partners, governments and other individuals who have worked tirelessly to make this unique aircraft a reality, and we thank them one and all. Our mission at Orbis is to bring the world together to fight blindness, and the Flying Eye Hospital is an important tool for achieving this. It is an equal-parts teacher, envoy and advocate for the right to sight. We are excited to start this new chapter in Orbis history here in Shenyang, China.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7316251-orbis-flying-eye-hospital/
Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to customers in the US market for the 2016-2017 season. Seqirus is the only influenza vaccine manufacturer to produce influenza vaccines using both egg-based and cell culture technologies, and the only provider in the US that offers both quadrivalent and trivalent influenza vaccines, as well as the only adjuvanted seasonal influenza vaccine.
Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine), Afluria® (Influenza Vaccine), and Fluvirin® (Influenza Virus Vaccine) in advance of the peak of influenza season.
“Seqirus is proud to be a major contributor to the prevention and control of influenza by offering healthcare providers and pharmacists with a range of clinically proven, innovative vaccination options that help protect people against the debilitating effects of the disease,” said Brent MacGregor, Senior Vice President, Commercial Operations. “We are committed to being an early and reliable supplier of our influenza vaccines to help ensure that appropriate patients have plenty of time to get their annual immunization.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7902351-seqirus-franchise-shipment/
